Contezolid acefosamil sodium - CAS 1807365-35-0

Contezolid acefosamil sodium (MRX-4) is a novel orally active oxazolidinone antibiotic under investigation for the treatment of complicated skin and soft tissue infections (cSSTI) caused by drug-resistant Gram-positive bacteria. It possesses strong efficacy against these pathogens while significantly minimizing the risks of myelosuppression and monoamine oxidase inhibition (MAOI) [1][2].

Others, Monoamine Oxidase, Antibacterial, Antibiotic

Others, Microbiology/Virology, Neuroscience

1807330

C20H17F3N4NaO8P

552.33

CC(OP([O-])(N(c1nocc1)C[C@H]2CN(c3c(F)c(F)c(N4CCC(C=C4)=O)c(F)c3)C(O2)=O)=O)=O.[Na+]

-20°C

Ice Packs

Small Compound